SUNSCREEN

SUNSCREEN was reported 1980 times

These side effects are most commonly reported by patients taking SUNSCREEN:

# Side effect Count
0 RASH 15
1 ACNE 10
2 SUNBURN 10
3 ERYTHEMA 9
4 DRY SKIN 8
5 MALIGNANT MELANOMA 8
6 HEADACHE 7
7 OFF LABEL USE 7
8 APPLICATION SITE ERYTHEMA 6
9 APPLICATION SITE PAIN 6
10 DERMATITIS 6
11 PAIN 6
12 PHOTOSENSITIVITY REACTION 6
13 SWELLING FACE 6
14 ARTHRALGIA 5
15 BLISTER 5
16 CONDITION AGGRAVATED 5
17 DEPRESSION 5
18 DIARRHOEA 5
19 DRUG INEFFECTIVE 5
20 FATIGUE 5
21 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5
22 PRODUCT USE ISSUE 5
23 PRURITUS 5
24 PSORIASIS 5
25 SKIN EXFOLIATION 5
26 XEROSIS 5
27 BASAL CELL CARCINOMA 4
28 DRUG HYPERSENSITIVITY 4
29 DRY EYE 4
30 ECZEMA 4
31 HYPERSENSITIVITY 4
32 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4
33 MALAISE 4
34 PAIN OF SKIN 4
35 SKIN BURNING SENSATION 4
36 SOMNOLENCE 4
37 THERAPEUTIC RESPONSE UNEXPECTED 4
38 ANXIETY 3
39 ASTHENIA 3
40 BURNING SENSATION 3
41 CHEILITIS 3
42 COUGH 3
43 HEART RATE INCREASED 3
44 HOSPITALISATION 3
45 ILLNESS 3
46 INTENTIONAL PRODUCT MISUSE 3
47 MOOD ALTERED 3
48 NAUSEA 3
49 PIGMENTATION DISORDER 3
50 RASH ERYTHEMATOUS 3
51 SENSITIVE SKIN 3
52 SKIN DISCOLOURATION 3
53 SKIN HYPERPIGMENTATION 3
54 SKIN IRRITATION 3
55 UNDERDOSE 3
56 URTICARIA 3
57 WEIGHT DECREASED 3
58 ABDOMINAL DISCOMFORT 2
59 ABDOMINAL PAIN UPPER 2
60 ABNORMAL LOSS OF WEIGHT 2
61 ACNE CYSTIC 2
62 ADVERSE EVENT 2
63 APPLICATION SITE DISCHARGE 2
64 APPLICATION SITE DISCOLOURATION 2
65 APPLICATION SITE EXFOLIATION 2
66 BACK PAIN 2
67 CHOLECYSTITIS ACUTE 2
68 CHOLESTASIS 2
69 CONTUSION 2
70 DEATH 2
71 DECREASED APPETITE 2
72 DRUG INTOLERANCE 2
73 DRY MOUTH 2
74 DYSPHAGIA 2
75 DYSPNOEA 2
76 EYE IRRITATION 2
77 EYE PAIN 2
78 FALL 2
79 GASTROINTESTINAL HAEMORRHAGE 2
80 HYPERHIDROSIS 2
81 IMMUNE SYSTEM DISORDER 2
82 IMMUNE-MEDIATED HEPATITIS 2
83 INFECTION 2
84 INFLAMMATION 2
85 INTENTIONAL PRODUCT USE ISSUE 2
86 INTENTIONAL UNDERDOSE 2
87 JOINT SWELLING 2
88 LENTIGO 2
89 LUNG NEOPLASM MALIGNANT 2
90 MELANOCYTIC NAEVUS 2
91 MILIARIA 2
92 MIOSIS 2
93 MUSCLE SPASMS 2
94 MYALGIA 2
95 OVERDOSE 2
96 PAIN IN EXTREMITY 2
97 PERIPHERAL SWELLING 2
98 PNEUMONIA 2
99 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2
100 PRODUCT DOSE OMISSION ISSUE 2
101 PRODUCT QUALITY ISSUE 2
102 PSORIATIC ARTHROPATHY 2
103 PYREXIA 2
104 RASH MACULAR 2
105 RASH PAPULAR 2
106 RASH PRURITIC 2
107 SEBORRHOEIC KERATOSIS 2
108 SEIZURE 2
109 SKIN HAEMORRHAGE 2
110 SKIN LESION 2
111 SKIN WARM 2
112 SQUAMOUS CELL CARCINOMA 2
113 SWELLING 2
114 TACHYCARDIA 2
115 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2
116 THERAPEUTIC PRODUCT INEFFECTIVE 2
117 ABDOMINAL DISTENSION 1
118 ABDOMINAL PAIN 1
119 ACCIDENTAL EXPOSURE TO PRODUCT 1
120 ACTINIC KERATOSIS 1
121 ACUTE KIDNEY INJURY 1
122 ACUTE PULMONARY OEDEMA 1
123 ADDISON^S DISEASE 1
124 ALANINE AMINOTRANSFERASE INCREASED 1
125 ALOPECIA 1
126 AMMONIA INCREASED 1
127 ANAEMIA 1
128 ANAL FISTULA 1
129 ANGIOPATHY 1
130 APPLICATION SITE HAEMORRHAGE 1
131 APPLICATION SITE IRRITATION 1
132 APPLICATION SITE NODULE 1
133 APPLICATION SITE PRURITUS 1
134 APPLICATION SITE RASH 1
135 APPLICATION SITE SCAB 1
136 APPLICATION SITE SWELLING 1
137 APPLICATION SITE VESICLES 1
138 ARTHROPOD STING 1
139 ASCITES 1
140 ASPARTATE AMINOTRANSFERASE INCREASED 1
141 ASPIRATION 1
142 ASTHMA 1
143 ATRIAL FIBRILLATION 1
144 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1
145 BACK DISORDER 1
146 BACTERIAL INFECTION 1
147 BALANCE DISORDER 1
148 BLOOD CALCIUM INCREASED 1
149 BLOOD CHOLESTEROL INCREASED 1
150 BLOOD CREATINE PHOSPHOKINASE INCREASED 1
151 BLOOD GLUCOSE INCREASED 1
152 BLOOD PRESSURE DECREASED 1
153 BLOOD PRESSURE INCREASED 1
154 BRONCHOSPASM 1
155 C-REACTIVE PROTEIN 1
156 CARDIAC MURMUR 1
157 CARDIOMEGALY 1
158 CATARACT OPERATION 1
159 CEREBROVASCULAR ACCIDENT 1
160 CHEMICAL BURN 1
161 CHEMICAL BURNS OF EYE 1
162 CHEST PAIN 1
163 CONFUSIONAL STATE 1
164 CONJUNCTIVITIS ALLERGIC 1
165 CONSTIPATION 1
166 CONTRAINDICATED PRODUCT ADMINISTERED 1
167 CONVULSION 1
168 COVID-19 1
169 DEHYDRATION 1
170 DERMATITIS CONTACT 1
171 DERMATITIS PSORIASIFORM 1
172 DIABETES MELLITUS 1
173 DISABILITY 1
174 DISCOMFORT 1
175 DISEASE PROGRESSION 1
176 DISEASE RECURRENCE 1
177 DROOLING 1
178 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1
179 DRUG EFFECT INCOMPLETE 1
180 DRUG EFFECT LESS THAN EXPECTED 1
181 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
182 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
183 DYSPEPSIA 1
184 DYSPNOEA EXERTIONAL 1
185 ENCEPHALITIS 1
186 ENDOMETRIOSIS 1
187 EPISTAXIS 1
188 EXPIRED PRODUCT ADMINISTERED 1
189 EXPOSURE TO MOULD 1
190 EYE OEDEMA 1
191 FACIAL ASYMMETRY 1
192 FEELING HOT 1
193 FLATULENCE 1
194 FLUSHING 1
195 FREQUENT BOWEL MOVEMENTS 1
196 FUNGAL OESOPHAGITIS 1
197 GAIT DISTURBANCE 1
198 GASTRIC ULCER 1
199 GASTROENTERITIS VIRAL 1
200 GASTROINTESTINAL DISORDER 1
201 GASTROINTESTINAL MELANOSIS 1
202 GENERAL PHYSICAL HEALTH DETERIORATION 1
203 GLOSSODYNIA 1
204 GUTTATE PSORIASIS 1
205 HAEMANGIOMA 1
206 HAEMATURIA 1
207 HAEMORRHAGE 1
208 HAIR COLOUR CHANGES 1
209 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1
210 HEPATITIS 1
211 HOT FLUSH 1
212 HYPERAESTHESIA 1
213 HYPEREOSINOPHILIC SYNDROME 1
214 HYPERGLYCAEMIA 1
215 HYPERKERATOSIS 1
216 HYPERSOMNIA 1
217 HYPERTENSION 1
218 HYPERTRIGLYCERIDAEMIA 1
219 HYPOPHAGIA 1
220 HYPOTENSION 1
221 IMMUNOSUPPRESSION 1
222 INCORRECT DOSAGE ADMINISTERED 1
223 INCORRECT DRUG ADMINISTRATION DURATION 1
224 INCORRECT PRODUCT ADMINISTRATION DURATION 1
225 INCORRECT PRODUCT STORAGE 1
226 INFLUENZA LIKE ILLNESS 1
227 INJECTION SITE DRYNESS 1
228 INJECTION SITE HAEMORRHAGE 1
229 INJECTION SITE MASS 1
230 INJECTION SITE PAIN 1
231 INJECTION SITE PRURITUS 1
232 INJECTION SITE REACTION 1
233 INJECTION SITE SWELLING 1
234 INJURY ASSOCIATED WITH DEVICE 1
235 INSOMNIA 1
236 INTENTIONAL DOSE OMISSION 1
237 JAUNDICE 1
238 JOINT WARMTH 1
239 LIP DRY 1
240 LIVER FUNCTION TEST INCREASED 1
241 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
242 LOW DENSITY LIPOPROTEIN INCREASED 1
243 MALIGNANT MELANOMA IN SITU 1
244 MENINGITIS VIRAL 1
245 METASTATIC MALIGNANT MELANOMA 1
246 MIGRAINE 1
247 MOBILITY DECREASED 1
248 MOUTH ULCERATION 1
249 MUSCLE DISORDER 1
250 MUSCULAR WEAKNESS 1
251 MUSCULOSKELETAL DISCOMFORT 1
252 MUSCULOSKELETAL STIFFNESS 1
253 MYELOSUPPRESSION 1
254 NAIL DISORDER 1
255 NASAL CONGESTION 1
256 NASAL OEDEMA 1
257 NASOPHARYNGITIS 1
258 NEPHROLITHIASIS 1
259 NERVE INJURY 1
260 NEUTROPENIA 1
261 NODULE 1
262 OCULAR HYPERAEMIA 1
263 OCULAR ICTERUS 1
264 OEDEMA 1
265 OESOPHAGEAL ULCER 1
266 ORGANISING PNEUMONIA 1
267 OSTEOMYELITIS 1
268 OXYGEN SATURATION DECREASED 1
269 PALPITATIONS 1
270 PETECHIAE 1
271 PINGUECULA 1
272 PLASMA CELL MYELOMA 1
273 POOR QUALITY PRODUCT ADMINISTERED 1
274 PRE-EXISTING CONDITION IMPROVED 1
275 PRODUCT ADMINISTRATION INTERRUPTED 1
276 PRODUCT DOSE OMISSION 1
277 PRODUCT STORAGE ERROR 1
278 PRODUCT USE IN UNAPPROVED INDICATION 1
279 PRODUCTIVE COUGH 1
280 PSYCHOTIC DISORDER 1
281 PULMONARY EMBOLISM 1
282 PULMONARY HAEMORRHAGE 1
283 PYOGENIC GRANULOMA 1
284 RALES 1
285 RASH MACULO-PAPULAR 1
286 RECTAL HAEMORRHAGE 1
287 RED BLOOD CELL COUNT INCREASED 1
288 RESPIRATORY DISORDER 1
289 RESPIRATORY FAILURE 1
290 RETINAL HAEMORRHAGE 1
291 SCAB 1
292 SCAR 1
293 SCLERODERMA 1
294 SCRATCH 1
295 SEBORRHOEIC DERMATITIS 1
296 SELF-INJURIOUS IDEATION 1
297 SEPSIS 1
298 SKIN ATROPHY 1
299 SKIN CANCER 1
300 SKIN DEPIGMENTATION 1
301 SKIN DISCOMFORT 1
302 SKIN DISORDER 1
303 SKIN MASS 1
304 SKIN PLAQUE 1
305 SKIN REACTION 1
306 SKIN TIGHTNESS 1
307 SLEEP DISORDER 1
308 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1
309 SOLAR DERMATITIS 1
310 SPINAL DISORDER 1
311 STOMATITIS 1
312 SUICIDAL IDEATION 1
313 SYSTEMIC LUPUS ERYTHEMATOSUS 1
314 TACHYPNOEA 1
315 THIRST 1
316 TONGUE ULCERATION 1
317 TRIGGER FINGER 1
318 TYPE 2 DIABETES MELLITUS 1
319 UPPER RESPIRATORY TRACT INFECTION 1
320 URINARY INCONTINENCE 1
321 URINARY RETENTION 1
322 VASCULAR INJURY 1
323 VASCULITIS 1
324 VISION BLURRED 1
325 VITILIGO 1
326 VITREOUS HAEMORRHAGE 1
327 VOMITING 1
328 VON WILLEBRAND^S DISEASE 1
329 WALKING DISABILITY 1
330 WEIGHT INCREASED 1
331 WOUND 1